Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg,

Slides:

Advertisements

Similar presentations

Volume 56, Issue 5, Pages (November 2009)

Advertisements

Volume 72, Issue 1, Pages (July 2017)

Testosterone Therapy in Men With Prostate Cancer

Volume 58, Issue 5, Pages (November 2010)

Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer Marisa Warmuth,

Volume 64, Issue 5, Pages (November 2013)

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Debra E. Irwin, Ian Milsom, Zoe Kopp, Paul Abrams European Urology

Volume 73, Issue 6, Pages (June 2018)

Volume 51, Issue 4, Pages (April 2007)

Volume 70, Issue 4, Pages (October 2016)

Volume 71, Issue 5, Pages (May 2017)

Prostate Cancer Epidemic in Sight?

F. Chung, R. Subramanyam, P. Liao, E. Sasaki, C. Shapiro, Y. Sun

European Urology Oncology

What is New in Hormone Therapy for Prostate Cancer in 2007?

European Urology Oncology

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Volume 184, Issue 4, Pages (October 2010)

Volume 70, Issue 5, Pages (November 2016)

Volume 71, Issue 6, Pages (June 2017)

Counselling the Prostate Cancer Patient

Volume 73, Issue 4, Pages (April 2018)

Volume 63, Issue 4, Pages (April 2013)

Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients Timo F.W. Soeterik,

Volume 73, Issue 2, Pages (February 2018)

Prostate Cancer Epidemic in Sight?

Thromboembolic Events Following Surgery for Prostate Cancer

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,

Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers Pasquale Rescigno, David Lorente, David Dolling, Roberta Ferraldeschi, Daniel.

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

Volume 63, Issue 3, Pages (March 2013)

Volume 62, Issue 4, Pages (October 2012)

Volume 65, Issue 6, Pages (June 2014)

Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer Valeria.

Volume 50, Issue 5, Pages (November 2006)

National Norwegian Practice Patterns for Surgical Treatment of Kidney Cancer Tumors ≤7cm: Adherence to Changes in Guidelines May Improve Overall Survival

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial Eva Johansson,

Anna Grenabo Bergdahl, Erik Holmberg, Sue Moss, Jonas Hugosson

Volume 72, Issue 4, Pages (October 2017)

Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer– specific Mortality: Competition Between Age and Time to Biochemical Failure

Mustapha A. El Lakis, MD, Stephen J

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

European Urology Oncology

Volume 68, Issue 1, Pages (July 2015)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

European Urology Oncology

Intermittent Hormone Therapy: What Is Its Place in Clinical Practice?

Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer Amar U. Kishan, Rahul.

Long-Term Hormonal Therapy: Who Would Benefit?

Volume 59, Issue 4, Pages (April 2011)

Trend of Adverse Stage Migration in Patients Treated with Radical Prostatectomy for Localized Prostate Cancer Felix Preisser, Michele Marchioni, Sebastiano.

Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial Martin Nyberg, Jonas.

Volume 72, Issue 1, Pages (July 2017)

A Systematic Review of Biocompatible Cardiopulmonary Bypass Circuits and Clinical Outcome Marco Ranucci, MD, Anna Balduini, AHA, Antonio Ditta, CCP,

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review Alexey Surov, Hans Jonas Meyer, Andreas.

Volume 74, Issue 6, Pages (December 2018)

Preventing Osteoporosis in Men Taking Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis Joseph Sargon Joseph, Vincent.

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 51, Issue 5, Pages (May 2007)

Salvage Local Treatments After Focal Therapy for Prostate Cancer

European Urology Oncology

European Urology Oncology

European Urology Oncology

Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood Jan F.M. Verbeek,

Presentation transcript:

Satisfaction with Care Among Men with Localised Prostate Cancer: A Nationwide Population-based Study Oskar Bergengren, Hans Garmo, Ola Bratt, Lars Holmberg, Eva Johansson, Anna Bill-Axelson European Urology Oncology Volume 1, Issue 1, Pages 37-45 (May 2018) DOI: 10.1016/j.euo.2018.02.003 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Flow chart showing patient participation and treatment. European Urology Oncology 2018 1, 37-45DOI: (10.1016/j.euo.2018.02.003) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Forest plot showing the odds ratio (95% confidence interval) for all participants who answered the main outcome question. The odds ratio indicates the probability of advancing one step on the seven-point visual digital scale for overall satisfaction with care when comparing the highest versus the lowest possible response. Adjusted for age, marital status, fatherhood, profession, education, Charlson comorbidity index (CCI), and psychiatric comorbidity. Ref.=reference. European Urology Oncology 2018 1, 37-45DOI: (10.1016/j.euo.2018.02.003) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 3 Bar charts showing percentage differences between treatment groups. AS=active surveillance; RP=radical prostatectomy; RT=radiotherapy. European Urology Oncology 2018 1, 37-45DOI: (10.1016/j.euo.2018.02.003) Copyright © 2018 European Association of Urology Terms and Conditions